Ratings Arvida Group Limited

Equities

ARV

NZARVE0001S5

End-of-day quote New Zealand S.E. Other stock markets 06:00:00 2024-05-09 pm EDT			5-day change	1st Jan Change
0.99 ^NZD	0.00%		-6.60%	-10.00%

May. 01	New Zealand Shares Decline on Likely Hawkish US Fed Stance	MT
May. 01	Arvida Group Completes Sale of Strathallan Village Property	MT

Strengths

The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
The company appears to be poorly valued given its net asset value.
The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.

Weaknesses

One of the major weak points of the company is its financial situation.
Based on current prices, the company has particularly high valuation levels.
Over the past twelve months, analysts' opinions have been revised negatively.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Healthcare Facilities & Services

	1st Jan change	Capi.	Investor Rating	ESG Refinitiv
ARVIDA GROUP LIMITED	-10.00%	435M		B-
ORPEA	-17.59%	2.39B		B-
NATIONAL HEALTHCARE CORPORATION	+2.74%	1.46B	-	C+
AMVIS HOLDINGS, INC.	-25.96%	1.43B		-
BROOKDALE SENIOR LIVING INC.	+21.31%	1.36B		B
SIENNA SENIOR LIVING INC.	+31.77%	809M	-	B
SONIDA SENIOR LIVING, INC.	+234.05%	424M	-	D+
MEDITERRANEAN TOWERS LTD.	-3.59%	341M	-	-
HUMANA AB	+9.41%	136M		B
GOLDEN HOUSE LTD	+46.62%	95.92M	-	-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes